Journal
LUPUS
Volume 20, Issue 2, Pages 206-218Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/0961203310395803
Keywords
anticardiolipin; antiphospholipid; aspirin; hydroxychloroquine; lupus anticoagulant; prevention; stroke; thrombosis; warfarin
Categories
Funding
- Department of Education, Universities and Research of the Basque Government
Ask authors/readers for more resources
The antiphospholipid syndrome (APS) is defined by the presence of thrombosis and/or pregnancy morbidity in combination with the persistent presence of circulating antiphospholipid antibodies: lupus anticoagulant, anticardiolipin antibodies and/or anti-beta 2-glycoprotein I antibodies in medium to high titers. The management of thrombosis in patients with APS is a subject of controversy. This set of recommendations is the result of an effort to produce guidelines for therapy within a group of specialist physicians in Cardiology, Neurology, Hematology, Rheumatology and Internal Medicine, with a clinical and research focus on APS. Lupus (2011) 20, 206-218.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available